NM
The startup develops transcatheter heart valve therapies specifically designed to treat heart failure by preventing structural heart damage. Their technology provides a minimally invasive solution that enhances patient outcomes and reduces the need for open-heart surgery.
Updated 18 months ago
Funding
$450K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MI
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops transcatheter heart valve therapies specifically designed to treat heart failure by preventing structural heart damage. Their technology provides a minimally invasive solution that enhances patient outcomes and reduces the need for open-heart surgery.